TG Therapeutics Announces Data from the UNITY-CLL Phase 3 Trial Presented at the 63rd American Society of Hematology (ASH) Annual Meeting

Frank Burrell
Scientific Storytelling

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement